Obesity in the 2020s and Beyond: A Multidisciplinary Overview
A Special Issue of Journal of Clinical Medicine (ISSN 2077-0383) belonging to the section "Pharmacology".
Deadline for manuscript submissions: 25 March 2027 | Viewed by 3937
Editor
Interests: cardiometabolic diseases; clinical pharmacology; evidence-based medicine; pharmacoeconomics; pharmacovigilance; real-world evidence
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce the launch of a new Special Issue in the Journal of Clinical Medicine entitled “Obesity in the 2020s and Beyond: A Multidisciplinary Overview”. This Special Issue seeks to provide a comprehensive and forward-looking synthesis of the rapidly evolving landscape of obesity research, spanning its biological foundations, clinical manifestations, and population-level impact.
Obesity remains one of the most pressing global health challenges of our time, intricately linked with a wide spectrum of metabolic, mechanical, and psychological complications, as well as reduced life expectancy. In this context, the Special Issue aims to capture recent advances in the understanding, detection, prevention, and management of obesity and its associated complications, with an emphasis on translational relevance and clinical applicability.
We particularly welcome contributions addressing, but not limited to, public health and epidemiology, and innovations in diagnostics, including biomarkers and multi-omics approaches relevant to clinical practice. Submissions exploring personalized and precision medicine strategies, as well as advances in lifestyle, pharmacological, and interventional therapies and procedures—including comparative effectiveness and safety profiles—are strongly encouraged. Particular emphasis will be placed on contemporary anti-obesity pharmacotherapy, including currently approved treatments as well as emerging therapeutic targets and novel molecules in the clinical development pipeline.
The Special Issue is also open to work addressing obesity and its comorbidities across the lifespan, including studies in pediatric, geriatric, and pregnancy populations, as well as in individuals with genetic or syndromic forms of obesity. We particularly encourage robust evidence derived from randomized clinical trials, well-designed observational studies, and state-of-the-art systematic or narrative reviews that meaningfully advance the field.
In line with contemporary standards in clinical and public health research, all submissions are expected to employ person-first and destigmatizing language and adhere to the highest ethical and reporting standards.
We look forward to your valuable contributions to this timely and important collection.
Dr. Andrej Belančić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obesity
- anti-obesity pharmacotherapy
- clinical pharmacology
- pharmacovigilance
- cardiometabolic diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
